CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ: IVGN) today announced that Mark Smedley, Invitrogen’s Global Head of Operations, has been appointed to lead the integration team for the combination of Invitrogen and Applera’s Applied Biosystems Group (NYSE: ABI).